Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited has successfully completed the placing of 156,000,000 new shares, raising net proceeds of HK$2,168.2 million. The funds will be used primarily for capital expenditure on manufacturing facilities, including the Inner Mongolia and Zhuhai plants, as well as for expanding international business and general corporate purposes.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on manufacturing and distributing pharmaceutical products, with a market emphasis on expanding its international business and strengthening external collaborations.
Average Trading Volume: 13,892,600
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.54B
See more insights into 3933 stock on TipRanks’ Stock Analysis page.